Drugs / BHVI1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04301323 | Oct 2019 → Jun 2022 | myopia | Hai Yen Eye Care | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BHVI1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04301323 ↗ |
| Route | Other | “receive BHVI1 eye-drops once nightly” NCT04301323 ↗ |